Department of Radiation Oncology/IBDC CNRS UMR 6543, Anti-Cancer Centre Antoine-Lacassagne, University Nice Sophia-Antipolis, Nice, France.
Clin Oncol (R Coll Radiol). 2011 Nov;23(9):579-86. doi: 10.1016/j.clon.2011.04.013. Epub 2011 May 31.
To assess the efficacy of surgery and high-dose split-course radiotherapy in sinonasal head and neck mucosal melanoma (SHNMM).
Between 1991 and 2006, 23 patients (median age 73 years, male:female ratio 0.4) with non-metastatic SHNMM underwent surgery and postoperative radiotherapy, two had exclusive radiotherapy. Radiotherapy consisted of three series of 18Gy (3×6Gy every other day for 1 week) with 3 week planned treatment breaks. Chi-squared tests, Kaplan-Meyer method and Log-rank test were used to assess prognostic factors for survival and local control.
There were 20 nasal cavity tumours; 12 of these involved more than one sinonasal site. One patient (4%) had lymphadenopathies at diagnosis. Six SHNMMs (24%) were amelanotic. The median follow-up was 39 months. Fourteen patients had en bloc surgery, 16 underwent radiation (14 postoperative, two exclusive). Eleven patients had local relapse, three had regional relapse and three had bone or liver metastases. Five year local control was 49±12%. Five year overall and SHNMM-specific survival was 38±12% and 62±12%, respectively. Five patients were alive without disease after 5 years and three after 10 years. En bloc excision (tumour removed in one piece) was prognostic for survival.
En bloc surgery was a prognostic factor on outcomes for local control and survival in this series. Data from the literature have shown that postoperative radiation therapy improves local control. Most series were carried out with conventional fractionation. The effect of planned breaks (split-course radiotherapy) may be deleterious, as suggested in this series. Therefore, split-course radiotherapy cannot be recommended for SHNMM.
评估手术和大剂量分割疗程放疗在鼻腔鼻窦头颈部黏膜黑色素瘤(SHNMM)中的疗效。
1991 年至 2006 年间,23 例非转移性 SHNMM 患者(中位年龄 73 岁,男女比例 0.4)接受了手术和术后放疗,其中 2 例仅接受放疗。放疗包括 3 个系列的 18Gy(3×6Gy,每隔一天,每周 1 次,共 3 周的计划治疗休息期)。采用卡方检验、Kaplan-Meier 法和 Log-rank 检验评估生存和局部控制的预后因素。
有 20 例鼻腔肿瘤;其中 12 例累及一个以上鼻窦部位。1 例患者(4%)在诊断时出现淋巴结病变。6 例 SHNMM(24%)为无黑色素瘤。中位随访时间为 39 个月。14 例患者行整块切除术,16 例行放疗(14 例术后,2 例单纯放疗)。11 例患者出现局部复发,3 例出现区域复发,3 例出现骨或肝转移。5 年局部控制率为 49±12%。5 年总生存率和 SHNMM 特异性生存率分别为 38±12%和 62±12%。5 例患者在 5 年后无疾病生存,3 例患者在 10 年后无疾病生存。整块切除(整块切除肿瘤)是生存的预后因素。
在本系列中,整块切除术是局部控制和生存的预后因素。文献中的数据表明,术后放疗可提高局部控制率。大多数系列都是采用常规分割进行的。本系列研究表明,计划休息(分割疗程放疗)可能有害,因此,不推荐对 SHNMM 采用分割疗程放疗。